Overview

• Peer-reviewed studies in the European Journal of Clinical Nutrition and the Journal of Diabetes & Metabolic Disorders published on August 6 demonstrate that controlled consumption of Safeda, Dasheri and Langra mangoes yields similar or lower glycemic responses than white bread and reduces blood sugar variability.
• An eight-week randomized trial of 35 adults with type 2 diabetes found daily intake of 250 g of mango led to reductions in fasting blood glucose, HbA1c, insulin resistance, body weight and waist circumference, alongside increased HDL cholesterol.
• Researchers recommend replacing refined carbohydrates at breakfast with portion-controlled mango servings paired with protein sources such as milk or curd to mitigate post-meal blood sugar spikes.
• Both trials received ethics approvals, were registered on ClinicalTrials.gov and were funded by the Indian Council of Medical Research, underscoring the studies’ methodological rigor.
• Experts caution that inclusion of mango in diabetic meal plans requires strict medical supervision and recommend updating formal dietary guidelines to reflect these findings responsibly.